Q4 2021 Athira Pharma Inc Earnings Call Transcript
Welcome to Athira Pharma's conference call to discuss its full-year 2021 financial results and business update. At this time, all participants are in a listen-only mode. Following the conclusion of the prepared remarks, we will conduct a question-and-answer session and instructions will follow at that time. This conference call is being recorded today, March 24, 2022.
I would like to turn the conference call over to Julie Rathbun, Head of Investor and Public Relations at Athira Pharma.
Thank you, operator. Following the close of the US financial market today, we issued full-year 2021 financial results and recent business updates. This press release can be found on the investors section of our website.
Before we begin, I'd like to remind you that during this call, management will make forward-looking statements, which may include statements about research and clinical development plans and timelines and results of operations, the timing of and results from clinical trials and preclinical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
